Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

DTaP vaccine - Serum Institute of India

Next Previous
Search
Drug Profile

DTaP vaccine - Serum Institute of India

Alternative Names: Acellular pertusis vaccines - Serum Institute of India; Diphtheria tetanus-acellular pertussis vaccine - Serum Institute of India

Latest Information Update: 09 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Serum Institute of India
  • Class Bacterial vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Diphtheria; Pertussis; Tetanus

Most Recent Events

  • 09 Mar 2021 Phase-II/III development is ongoing for Tetanus, Pertussi and Diphtheria (In adolescents, In adults, In children, Prevention) (CTRI/2018/06/014617)
  • 03 Nov 2020 GenKyoTex has been acquired by Calliditas Therapeutics
  • 02 Jul 2018 Phase-II/III clinical trials in Diphtheria (Prevention, In adults, In adolescents, In children) in India (IM) (CTRI2018-06-014617)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top